Breaking News

C2 Pharma Expands API Portfolio

Adds Digoxin micronized grade, Homatropine Hydrobromide and multiple products under tech transfer and development.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

C2 Pharma s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, continues to build its active pharmaceutical ingredient (API) and botanical extracts product portfolio. The most recent addition enhances the previously announced Digoxin API product offer with the inclusion of a micronized grade for Digoxin from two different manufacturing sites. Multiple niche APIs and botanical extract products are also currently in technical transfer o...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters